SCHEMBL4929581

SCHEMBL4929581

CC1(C)CC(=O)c2c(S(C)(=O)=O)sc(C(=O)OCc3ccc(C(F)(F)F)cc3F)c2C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
PKM P14618 2/20 0.46
LRRK2 Q5S007 1/20 0.38
LMNA P02545 3/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
FFAR1 O14842 1/20 0.36
IDO1 P14902 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TRPV1 Q8NER1 2/20 0.33
KCNH2 Q12809 1/20 0.33
GPR119 Q8TDV5 1/20 0.33
ENPP2 Q13822 3/20 0.33
ATXN2 Q99700 3/20 0.33
TP53 P04637 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.32
EGFR P00533 1/20 0.32
ERBB2 P04626 1/20 0.32
PDGFRB P09619 1/20 0.32
KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4918258 0.87 ALDH1A1 (0.47) ALDH1A1PKMLRRK2LMNAKDM4E
SCHEMBL4927718 0.85 ALDH1A1 (0.47) ALDH1A1PKMLRRK2LMNAKDM4E
SCHEMBL4929847 0.83 ALDH1A1 (0.48) ALDH1A1PKMLRRK2LMNAKDM4E
SCHEMBL4923939 0.80 ALDH1A1 (0.46) ALDH1A1PKMLRRK2LMNAKDM4E
SCHEMBL4925499 0.80 ALDH1A1 (0.47) ALDH1A1PKMLRRK2LMNAKDM4E
SCHEMBL13791613 0.78 ALDH1A1 (0.54) ALDH1A1PKMLRRK2LMNAKDM4E
SCHEMBL7433903 0.77 ALDH1A1 (0.73) ALDH1A1PKMLRRK2LMNAKDM4E
SCHEMBL4928860 0.77 ALDH1A1 (0.47) ALDH1A1PKMLRRK2LMNAKDM4E
SCHEMBL4929382 0.76 ALDH1A1 (0.50) ALDH1A1PKMLRRK2LMNAKDM4E
SCHEMBL4930488 0.76 ALDH1A1 (0.48) ALDH1A1PKMLRRK2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
EP-1765814-A1 CONDENSED THIOPHENE DERIVATIVES AND THEIR USE AS CYCLIC GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2007-03-28 EP disclosed
WO-2006003096-A1 CONDENSED THIOPHENE DERIVATIVES AND THEIR USE AS CYCLIC GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists GLP1R, GIPR, GCGR ALDH1A1 2002/4885PKM 2177/4885LRRK2 327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.